The loss of pancreatic islet NADPH oxidase (NOX)2 improves islet transplantation

• Published in: Redox biology 2022-09, Vol.55, p.102419, Article 102419
• Main Authors: Wrublewsky, Selina, Glas, Julia, Carlein, Christopher, Nalbach, Lisa, Hoffmann, Markus Daniel Alexander, Pack, Mandy, Vilas-Boas, Eloisa Aparecida, Ribot, Nathan, Kappl, Reinhard, Menger, Michael D., Laschke, Matthias W., Ampofo, Emmanuel, Roma, Leticia Prates
• Format: Article
• Language: English
• Subjects: Diabetes; HO-1; Insulin secretion; Islet transplantation; NADPH oxidase; NOX2; Nrf2; Research Paper; Revascularization; ROS; β-cells
• ISSN: 2213-2317; 2213-2317
• DOI: 10.1016/j.redox.2022.102419

Islet transplantation is a promising treatment strategy for type 1 diabetes mellitus (T1DM) patients. However, oxidative stress-induced graft failure due to an insufficient revascularization is a major problem of this therapeutic approach. NADPH oxidase (NOX)2 is an important producer of reactive oxygen species (ROS) and several studies have already reported that this enzyme plays a crucial role in the endocrine function and viability of β-cells. Therefore, we hypothesized that targeting islet NOX2 improves the outcome of islet transplantation. To test this, we analyzed the cellular composition and viability of isolated wild-type (WT) and Nox2−/− islets by immunohistochemistry as well as different viability assays. Ex vivo, the effect of Nox2 deficiency on superoxide production, endocrine function and anti-oxidant protein expression was studied under hypoxic conditions. In vivo, we transplanted WT and Nox2−/− islets into mouse dorsal skinfold chambers and under the kidney capsule of diabetic mice to assess their revascularization and endocrine function, respectively. We found that the loss of NOX2 does not affect the cellular composition and viability of isolated islets. However, decreased superoxide production, higher glucose-stimulated insulin secretion as well as expression of nuclear factor erythroid 2-related factor (Nrf)2, heme oxygenase (HO)-1 and superoxide dismutase 1 (SOD1) was detected in hypoxic Nox2−/− islets when compared to WT islets. Moreover, we detected an early revascularization, a higher take rate and restoration of normoglycemia in diabetic mice transplanted with Nox2−/− islets. These findings indicate that the suppression of NOX2 activity represents a promising therapeutic strategy to improve engraftment and function of isolated islets.